Skip to main content
. 2023 Jul 7;14:1209485. doi: 10.3389/fpsyt.2023.1209485

Table 1.

Sociodemographic and clinical characteristics of the sample.

Female (n = 127; 54.7%) Male (n = 105; 45.3%) Total sample (N = 232) Statistics
Age median (mean ± SD) 21 (23.0 ± 5.3) 22 (23.6 ± 5.3) 22 (23.2 ± 5.3) U = 6,109.5, p = 0.271; r=0.072
Education years median (mean ± SD) 13 (13.9 ± 2.4) 13 (13.3 ± 2.7) 13 (13.6 ± 2.6) U = 5,868.0, p = 0.113; r=0.104
Country n (%) χ2(4) = 18.242, p = 0.001; V = 0.280
   Germany 74 (58.3%) 49 (46.7%) 123 (53.0%)
   England 13 (10.2%) 6 (5.7%) 19 (8.2%)
   Switzerland 3 (2.4%) 18 (17.1%) 21 (9.0 %)
   Finland 18 (14.2%) 11 (10.5%) 29 (12.5 %)
   Italy 19 (15.0%) 21 (20.0) 40 (17.2 %)
Religion n (%) χ2(4) = 6.526, p = 0.163; V = 0.168
   Atheists 47 (37.0%) 46 (43.8%) 93 (40.0%)
   Christians 66 (52.0%) 55 (52.4%) 121 (52.1%)
   Other (55.6% Muslims) 14 (11.0%) 4 (3.8%) 18 (7.8%)
Marital status n (%) χ2(3) = 5.215, p = 0.157; V = 0.150
   Single 86 (67.7%) 83 (79.0%) 169 (72.8%)
   Married 6 (4.7%) 1 (1.0%) 7 (3.0%)
   Steady partnership 34 (26.8%) 20 (19.0%) 54 (23.3 %)
   Divorced 1 (0.8%) 1 (0.8%) 2 (0.9%)
Occupation n (%) χ2(1) = 19.202, p = 0.024; V = 0.288
   Full-time (incl. in school/training, full-time house-keeper) 79 (62.2%) 64 (60.9%) 143 (61.6%)
   Part-time (incl. others) 11 (4.7%) 8 (7.6%) 19 (8.2%)
   Unemployed/unable to work 37 (29.1%) 33 (31.4%) 70 (30.2%)
Current mental disorder n (%)
   Any disorders 99 (78.0%) 72 (68.6%) 171 (73.7%) χ2(1) = 2.2610, p = 0.134; V=0.106*
   Mood disorder 68 (53.5%) 49 (46.7%) 117 (50.4%) χ2(1) = 1.087, p = 0.356; V=0.068*
   Anxiety disorder 49 (38.6%) 23 (21.9%) 72 (31.0%) χ2(1) = 7.470, p = 0.007; V=0.179*
   Obsessive-compulsive disorder 12 (9.4%) 8 (7.6%) 20 (8.6%) χ2(1) = 0.224, p = 0.686; V=0.032*
   Somatization disorder 6 (4.7%) 7 (6.7%) 13 (5.6%) χ2(1) = 0.410, p = 0.575; V=0.042*
   Other disorders (e.g., eating or stress-related disorders) 16 (12.6%) 5 (4.8%) 21 (9.0%) χ2(1) = 4.288, p = 0.041; V=0.136*
CHR criteria n (%) χ2(9) = 10.957, p = 0.279; V = 0.217
GRFD only 6 (4.7%) 4 (3.8%) 10 (4.3%)
GRFD + COGDIS 2 (1.6%) 5 (4.8%) 7 (3.0%)
GRFD + APS 2 (1.6%) 3 (2.9%) 5 (2.1%)
GRFD + APS + COGDIS 4 (3.1%) 9 (8.6%) 13 (5.6%)
COGDIS only 28 (22.0%) 29 (27.6%) 57 (24.6%)
COGDIS + APS 41 (32.3%) 20 (19.0%) 61 (26.3%)
COGDIS + BIPS 1 (0.8%) 0 (0.0%) 1 (0.4%)
APS only 40 (31.5%) 32 (30.5%) 72 (31.0%)
APS + BIPS 1 (0.8%) 1 (1.0%) 2 (0.9%)
BIPS only 2 (1.6%) 2 (1.9%) 4 (1.7%)
APS n (%) 88 (69.3%) 65 (61.9%) 153 (65.9%) χ2(1) = 1.397, p = 0.267; V = 0.078*
BIPS n (%) 4 (3.1%) 3 (2.9%) 7 (3.0%) χ2(1) = 0.017, p = 0.897; V = 0.009
COGDIS n (%) 76 (59.8%) 63 (60.0%) 139 (41.9%) χ2(1) = 0.001, p = 1.000; V = 0.002*
GRFD n (%) 14 (11.0%) 21 (20.0%) 35 (15.0%) χ2(1)=3.615, p = 0.066; V = 0.125*
Schizotypal PD n (%) 4 (3.1%) 11 (10.5%) 15 (6.5%) χ2(1) = 5.102, p = 0.024; V = 0.148
Positive family history of psychosis n (%) 18 (14.2%) 16 (15.2%) 34 (14.7%) χ2(1) = 0.052, p = 0.819; V = 0.015
GF-S median (mean ± SD) 6 (6.63 ± 1.478) 6 (6.23 ± 1.429) 6 (6.30 ± 1.455) U = 6,170.0, p = 0.315; r = 0.066
GF-R median (mean ± SD) 6 (5.83 ± 1.773) 6 (5.71 ± 1.752) 6 (5.78 ± 1.749) U = 6,431.5, p = 0.637; r = −0.030
SIPS-P1 severity median (mean ± SD) 3 (2.22 ± 2.093) 0 (1.93 ± 2.053) 3 (2.09 ± 2.076) U = 6,180.5, p = 0.307; r = 0.067
SIPS-P2 severity median (mean ± SD) 0 (1.77 ± 2.071) 0 (1.77 ± 2.039) 0 (1.77 ± 2.052) U = 6,664.5, p = 0.995; r = −0.004
SIPS-P3 severity median (mean ± SD) 0 (0.13 ± 0.713) 0 (0.37 ± 1.171) 0 (0.24 ± 0.953) U = 6,244.0, p = 0.044; r = −0.132
SIPS-P4 severity median (mean ± SD) 3 (2.03 ± 2.055) 0 (1.39 ± 1.968) 0 (1.74 ± 2.037) U = 5,569.0, p = 0.017; r = −0.156
SIPS-P5 severity median (mean ± SD) 0 (0.70 ± 1.460) 0 (0.73 ± 1.619) 0 (0.72 ± 1.531) U = 6,629.5, p = 0.913; r = −0.007

*Fisher's test, used when any expected cell frequency was < 5. GRFD, Genetic risk and functional deterioration; COGDIS, Cognitive Disturbances; APS, Attenuated psychotic symptoms; BIPS, Brief limited psychotic symptoms; PD, Personality disorder; GF-S, Global Functioning—Social; GF-R, Global Functioning—Role; SIPS, Structured Interview for Psychosis-Risk Syndromes; SIPS-P1, Unusual thought content/delusional ideas; SIPS-P2, Suspiciousness/persecutory ideas; SIPS-P3, Grandiose ideas; SIPS-P4, Perceptual abnormalities/hallucinations; SIPS-5, Disorganized communication; V, Cramer's V with 0.1 = small effect, 0.3 = moderate effect, and 0.5 = large effect; r, Rosenthal's r with 0.1 = small effect, 0.3 = moderate effect, and 0.5 = large effect.